Towards the prevention of cancer treatment-related hearing loss
0 citationsNederlands Tijdschrift voor Keel-Neus-Oorheelkunde
Charlotte W. Duinkerken
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
11Publications signalées
125Citations signalées
2Affiliations récentes
Institutions déclarées
Domaines associés
Hearing, Cochlea, Tinnitus, GeneticsHearing Loss and RehabilitationVestibular and auditory disordersHead and Neck Cancer StudiesNonmelanoma Skin Cancer Studies
Publications récentes
A Prospective Multicenter Observational Study Investigating the Concordance Between Patient-Reported Hearing Loss and Commonly Used Ototoxicity Grading Systems in Patients Treated with Platinum-Based Chemotherapy
Anouk V. M. Burger, Charlotte W. Duinkerken, Eleonoor A. R. Theunissen, Anouk W. M. A. Schaeffers et autres
0 citationsAnnals of Otology Rhinology & Laryngology
Transtympanic sodium thiosulphate to prevent cisplatin-related hearing loss: a protocol for randomised controlled multicentre phase III trial, the SOUND trial
Anouk V. M. Burger, Charlotte W. Duinkerken, Jeroen C. Jansen, Stijn Keereweer et autres
1 citationBMJ Open
Treatment-related hearing loss in weekly versus triweekly cisplatin chemoradiation for head and neck cancer
Anouk V. M. Burger, Charlotte W. Duinkerken, Klaske E. van Sluis, Jan Paul de Boer et autres
4 citationsEuropean Archives of Oto-Rhino-Laryngology
The association between skeletal muscle mass and sensorineural hearing loss upon cisplatin‐based chemoradiotherapy in patients with head and neck squamous cell carcinoma
Anouk W. M. A. Schaeffers, Anouk V. M. Burger, Charlotte W. Duinkerken, Klaske E. van Sluis et autres
1 citationHead & Neck
The role of genetic variants in the prediction of hearing loss due to cisplatin chemoradiotherapy
Charlotte W. Duinkerken, Sabrina Chiodo, Katrina Hueniken, Michael Hauptmann et autres
2 citationsCancer Medicine
MART-1 TCR gene-modified peripheral blood T cells for the treatment of metastatic melanoma: a phase I/IIa clinical trial
Maartje W. Rohaan, Raquel Gomez-Eerland, Joost H. van den Berg, Marnix H. Geukes Foppen et autres
44 citationsImmuno-Oncology Technology
Transtympanic Sodium Thiosulfate for Prevention of Cisplatin-Induced Ototoxicity: A Randomized Clinical Trial
Charlotte W. Duinkerken, Vincent A. de Weger, Wouter A. Dreschler, Lisette van der Molen et autres
30 citationsOtology & Neurotology
Sensorineural Hearing Loss After Adoptive Cell Immunotherapy for Melanoma Using MART-1 Specific T Cells: A Case Report and Its Pathophysiology
Charlotte W. Duinkerken, Maartje W. Rohaan, Vincent A. de Weger, Peter J. F. M. Lohuis et autres
14 citationsOtology & Neurotology
Orthovoltage X-rays for Postoperative Treatment of Resected Basal Cell Carcinoma in the Head and Neck Area
Charlotte W. Duinkerken, Peter J. F. M. Lohuis, Marianne B. Crijns, Arash Navran et autres
11 citationsJournal of Cutaneous Medicine and Surgery
Orthovoltage for basal cell carcinoma of the head and neck: Excellent local control and low toxicity profile
Charlotte W. Duinkerken, Peter J. F. M. Lohuis, Wilma D. Heemsbergen, Biljana Zupan‐Kajcovski et autres
18 citationsThe Laryngoscope
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.